- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03301571
Right Ventricular Echocardiography in caRdiac SurgEry (ReVERSE)
Response in Right Ventricular Function to Change in Afterload, Preload and Inspired Oxygen in Patients Undergoing Coronary Artery Bypass Graft Surgery
Postoperative right ventricular (RV) dysfunction increases mortality and risk of cardiac failure after cardiac surgery substantially. A comprehensive understanding of this condition is paramount in order to achieve success in treatment and early diagnosis.
This study has two main aims.
Perioperative aim:
To investigate correlations between changes in echocardiographic measurements and hemodynamic changes at baseline and following coronary artery bypass graft (CABG) surgery.
Postoperative aim:
To evaluate changes in haemodynamics and echocardiographic parameters during separate physiological interventions (increase in preload/afterload, oxygen fraction, pacing modes (AAI/DDD/VVI)).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Clinical procedure:
For the operation standard procedures for anaesthesia, surgery and cardiopulmonary bypass will be used. This includes installment of a pulmonary artery catheter and performing a transesophageal echocardiography. For the purpose of this study additional TEE images and a transthoracic echocardiography (TTE) will be obtained in order to correlate different echocardiographic indices with haemodynamic measurements and investigate any differences between TTE and TEE measurements.
Transthoracic echocardiography (TTE):
Basic TTE will be performed after anaesthesia induction, before surgery commences and repeated immediately after arrival at the ICU.
Image acquisitions from TTE:
- 2D apical 4-chamber view for right ventricular fractional area change (RVFAC)
- M-mode tricuspid annular plane systolic excursion (TAPSE).
- M-mode lateral mitral annular plane systolic excursion (MAPSE) measurements
Transoesophageal echocardiography (TEE):
After probe placement and before commencing surgery a TEE will be performed. The probe will be left in place during surgery for continuous imaging. Standard views used for patient treatment will be acquired in accordance with the requirements of the treating anaesthesiologist and surgeon.
Additional views will be added in order to obtain standard 2D measures, M-mode measures, spectral doppler measures, myocardial doppler tissue imaging, strain and 3D measures of RV function.
Measurements will be performed at different stages throughout surgery following a period of relative hemodynamic stability defined as: 1 minute of no more than 10 beats/min variation in heart rate, maximum variation of 10 mmHg in mean arterial pressure, maximum variation of 3 mmHg in central venous pressure and no change in administration of vasoactive drugs. If hemodynamic stability cannot be achieved an annotation comment will be entered.
Time points for echocardiography:
TEE will be performed at four different time points during and immediately after surgery:
Stage 1: After induction of anaesthesia. Stage 2: After full sternotomy Stage 3: After completion of cardiopulmonary bypass Stage 4: Immediately after arrival at the ICU and will be repeated after each intervention
Interventions Each intervention will be investigated separately and before each intervention the patient will return to hemodynamic baseline.
Trendelenburg position for 5 minutes will be investigated. Following positive end-expiratory pressures will be investigated: 0 cm H2O, 5 cm H2O and 10 cm H2O.
Following fractions of inspired O2 will be investigated: 0.5 and 1.0 for 10 minutes at each setting.
Following pacemaker settings will be investigated: Atrioventricular pacing 10 bpm over the patients' intrinsic rhythm, atrial pacing 10 bpm over the patients' intrinsic rhythm, ventricular pacing 10 bpm over the patients' intrinsic rhythm
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Capital Region
-
Copenhagen, Capital Region, Denmark, 2100
- Rigshospitalet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Elective coronary artery bypass graft patients
- Normal left ventricular function defined as LVEF over 50 % on TTE preoperatively
Exclusion Criteria:
- Pre-existing right ventricular malformations
- Severe right ventricular impairment preoperatively
- Pre-existing non-sinus rhythm
- Pre-existing mitral valve stenosis or severe regurgitation
- Pre-existing pulmonary hypertension
- Pre-existing tricuspid valve stenosis or severe regurgitation
- Patients with contraindication to TEE probe placement such as oesophageal stricture or obstruction
- Patients with contraindication to Swan-Ganz catheter placement
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: All patients
All patients will receive the treatment (CABG) and postoperatively three different interventions:
|
Afterload: Three levels of positive end-expiratory pressure (PEEP) will be examined post-operatively: 0 cm H20, 5 cm H2O, 10 cm H2O Preload: Trendelenburg position for 5 minutes will be investigated
Following fractions of inspired O2 will be investigated: 0.5 and 1.0 for 10 minutes respectively
Following pacemaker settings will be investigated: Atrioventricular pacing 10 bpm over the patients' intrinsic rhythm, atrial pacing 10 bpm over the patients' intrinsic rhythm, ventricular pacing 10 bpm over the patients' intrinsic rhythm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in right ventricular function during CABG assessed with TAPSE
Time Frame: During a standard CABG operation
|
Assessing the change in RV function during CABG surgery
|
During a standard CABG operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Right ventricular function assessed with TAPSE after each intervention
Time Frame: Immediate postoperative period
|
Change in TAPSE after each intervention
|
Immediate postoperative period
|
Change in cardiac output measured with Swan-Ganz during CABG
Time Frame: During a standard CABG operation
|
Cardiac output measured with the thermodilution technique
|
During a standard CABG operation
|
Change in cardiac output measured with Swan-Ganz after each intervention
Time Frame: Immediate postoperative period
|
Cardiac output measured with the thermodilution technique
|
Immediate postoperative period
|
Response in right ventricular function parameter S' to each intervention
Time Frame: Immediate postoperative period
|
Change in S'
|
Immediate postoperative period
|
Response in right ventricular function parameter S' during CABG
Time Frame: During a standard CABG operation
|
Change in S'
|
During a standard CABG operation
|
Response in right ventricular function parameter Tei index to each intervention
Time Frame: Immediate postoperative period
|
Change in Tei index
|
Immediate postoperative period
|
Response in right ventricular function parameter Tei index during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in Tei index
|
During a standard CABG operation
|
Response in right ventricular function parameter RVFAC to each intervention
Time Frame: Immediate postoperative period
|
Change in RVFAC
|
Immediate postoperative period
|
Response in right ventricular function parameter RVFAC during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in RVFAC
|
During a standard CABG operation
|
Response in left ventricular function parameter MAPSE to each intervention
Time Frame: Immediate postoperative period
|
Change in MAPSE
|
Immediate postoperative period
|
Response in left ventricular function parameter MAPSE during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in MAPSE
|
During a standard CABG operation
|
Response in right ventricular function parameter strain % to each intervention
Time Frame: Immediate postoperative period
|
Change in strain %
|
Immediate postoperative period
|
Response in right ventricular function parameter strain % during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in strain %
|
During a standard CABG operation
|
Response in right ventricular function parameter strain rate to each intervention
Time Frame: Immediate postoperative period
|
Change in strain rate
|
Immediate postoperative period
|
Response in right ventricular function parameter strain rate during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in strain rate
|
During a standard CABG operation
|
Response in right ventricular function parameter RV size to each intervention
Time Frame: Immediate postoperative period
|
Change in RV size
|
Immediate postoperative period
|
Response in right ventricular function parameter RV size during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in RV size
|
During a standard CABG operation
|
Response in right ventricular function parameter pulmonary artery flow velocity to each intervention
Time Frame: Immediate postoperative period
|
Change in flow velocity in pulmonary artery
|
Immediate postoperative period
|
Response in right ventricular function parameter pulmonary artery flow velocity during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in flow velocity in pulmonary artery
|
During a standard CABG operation
|
Response in right ventricular function parameter RVEF to each intervention
Time Frame: Immediate postoperative period
|
Change in RVEF measured with 3D echo
|
Immediate postoperative period
|
Response in right ventricular function parameter RVEF during a standard CABG operation
Time Frame: During a standard CABG operation
|
Change in RVEF measured with 3D echo
|
During a standard CABG operation
|
Response in right ventricular function parameter RVEF during CABG
Time Frame: Immediate postoperative period
|
Change in RVEF measured with 3D echo
|
Immediate postoperative period
|
Change in cardiac output measured with Swan Ganz in response during a standard CABG operation
Time Frame: During a standard CABG operation
|
Following each intervention in the postoperative period cardiac output will be measured with the thermodilution technique.
|
During a standard CABG operation
|
Change in cardiac output measured with Swan Ganz in response to each intervention
Time Frame: Immediate postoperative period
|
Following each intervention in the postoperative period cardiac output will be measured with the thermodilution technique.
|
Immediate postoperative period
|
Change in hemodynamic pressures in response to each intervention
Time Frame: Immediate postoperative period
|
Following each intervention in the postoperative period hemodynamic pressures will be measured with the Swan Ganz catheter
|
Immediate postoperative period
|
Change in hemodynamic pressures during a standard CABG operation
Time Frame: During a standard CABG operation
|
Following each intervention in the postoperative period hemodynamic pressures will be measured with the Swan Ganz catheter
|
During a standard CABG operation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lars Grønlykke, MD, Rigshospitalet, Denmark
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17005565
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Right Ventricular Dysfunction
-
University of ChicagoRecruitingHeart Failure | Right Ventricular Dysfunction | Right Ventricular FailureUnited States
-
Semmelweis University Heart and Vascular CenterCompletedRight Ventricular Dysfunction | Right Heart Failure | Right Ventricular Failure | Mitral Valve DiseaseHungary
-
Centre Hospitalier Universitaire, AmiensRecruitingThoracic Surgery | Right VentricleFrance
-
NHS National Waiting Times Centre BoardNHS Greater Glasgow and Clyde; University of Glasgow; Royal London HospitalNot yet recruitingRight Ventricular DysfunctionUnited Kingdom
-
University of MinnesotaRecruitingRight Ventricular DysfunctionUnited States
-
Montreal Heart InstituteOlivier Lachance, MD; Melissa Parent, MD; Patrick Tawil, MD; Etienne Couture, MD... and other collaboratorsCompletedRight Ventricular Dysfunction | Right Heart Failure | Heart; Dysfunction Postoperative, Cardiac SurgeryCanada
-
Jewish General HospitalNot yet recruitingRight Ventricular Dysfunction | Left Ventricular Dysfunction | Quality of RecoveryCanada
-
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e...RecruitingRight Ventricular DysfunctionItaly
-
University of GiessenGerman Research FoundationUnknownRight Ventricular DysfunctionGermany
-
University Hospital DubravaUnknownRight Ventricular Dysfunction | Left Ventricular Dysfunction | Biventricular FailureCroatia
Clinical Trials on Change in preload and afterload
-
University of Colorado, DenverTerminatedHeart Failure, Systolic | Mechanical Circulatory Support | Cardiovascular HemodynamicsUnited States
-
University Hospital, Basel, SwitzerlandCompletedAcute Heart FailureSpain, Switzerland, Germany, Brazil, Bulgaria
-
University of AberdeenUniversity of JazanActive, not recruiting
-
University of BradfordCompleted
-
Umeå UniversityKuopio University Hospital; Sahlgrenska University Hospital, Sweden; Uppsala...TerminatedHydrocephalus, Normal PressureFinland, Sweden
-
University of OsloRecruitingIntellectual Disability | Autism Spectrum Disorder | Communication, NonverbalNorway
-
University of Texas Southwestern Medical CenterCompleted
-
Zealand University HospitalUniversity of Copenhagen; Danish Working Environment FundCompleted
-
Umeå UniversityRecruitingPostoperative Complications | Hypoxia | Abdominal SurgerySweden